Israel Englander Sutro Biopharma, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 4,361,893 shares of STRO stock, worth $18.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,361,893

Previous 4,735,963 7.9%

Holding current value

$18.1 Million

Previous $26.8 Million 52.24%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$2.92 - $5.33 $1.09 Million - $1.99 Million	-374,070 Reduced 7.9%	4,361,893 $12.8 Million
Q1 2024 May 15, 2024	BUY	$3.27 - $5.65 $10.5 Million - $18.1 Million	3,200,094 Added 208.36%	4,735,963 $26.8 Million
Q4 2023 Feb 14, 2024	BUY	$2.07 - $4.54 $66,809 - $146,528	32,275 Added 2.15%	1,535,869 $6.59 Million
Q2 2023 Aug 14, 2023	BUY	$4.25 - $5.88 $2.6 Million - $3.6 Million	611,978 Added 68.64%	1,503,594 $6.99 Million
Q1 2023 May 15, 2023	SELL	$4.48 - $8.45 $2.14 Million - $4.03 Million	-477,405 Reduced 34.87%	891,616 $4.12 Million
Q4 2022 Feb 14, 2023	SELL	$5.41 - $8.08 $6.32 Million - $9.44 Million	-1,168,049 Reduced 46.04%	1,369,021 $11.1 Million
Q3 2022 Nov 14, 2022	BUY	$5.17 - $7.11 $1.19 Million - $1.64 Million	230,278 Added 9.98%	2,537,070 $14.1 Million
Q2 2022 Aug 15, 2022	BUY	$3.41 - $8.95 $6.7 Million - $17.6 Million	1,964,661 Added 574.24%	2,306,792 $12 Million
Q1 2022 May 16, 2022	BUY	$7.78 - $15.31 $1.53 Million - $3.01 Million	196,496 Added 134.92%	342,131 $2.81 Million
Q4 2021 Feb 14, 2022	SELL	$14.25 - $23.53 $982,509 - $1.62 Million	-68,948 Reduced 32.13%	145,635 $2.17 Million
Q3 2021 Nov 15, 2021	SELL	$16.88 - $22.38 $4.45 Million - $5.9 Million	-263,537 Reduced 55.12%	214,583 $4.05 Million
Q2 2021 Aug 16, 2021	SELL	$18.03 - $23.82 $1.42 Million - $1.87 Million	-78,679 Reduced 14.13%	478,120 $8.89 Million
Q1 2021 May 17, 2021	BUY	$20.29 - $27.54 $5.83 Million - $7.91 Million	287,315 Added 106.62%	556,799 $12.7 Million
Q4 2020 Feb 16, 2021	SELL	$10.16 - $23.98 $505,256 - $1.19 Million	-49,730 Reduced 15.58%	269,484 $5.85 Million
Q3 2020 Nov 16, 2020	BUY	$7.44 - $13.15 $1 Million - $1.78 Million	135,067 Added 73.35%	319,214 $3.21 Million
Q2 2020 Aug 14, 2020	BUY	$7.24 - $11.05 $1.14 Million - $1.74 Million	157,672 Added 595.55%	184,147 $1.43 Million
Q1 2020 May 14, 2020	SELL	$6.19 - $12.16 $42,265 - $83,028	-6,828 Reduced 20.5%	26,475 $270,000
Q4 2019 Feb 14, 2020	BUY	$8.15 - $11.39 $59,217 - $82,759	7,266 Added 27.91%	33,303 $366,000
Q3 2019 Nov 14, 2019	BUY	$7.91 - $11.76 $58,787 - $87,400	7,432 Added 39.95%	26,037 $236,000
Q2 2019 Aug 15, 2019	SELL	$9.69 - $12.23 $184,642 - $233,042	-19,055 Reduced 50.6%	18,605 $212,000
Q1 2019 May 14, 2019	BUY	$8.8 - $11.87 $331,408 - $447,024	37,660 New	37,660 $429,000
Q4 2018 Feb 14, 2019	SELL	$8.69 - $14.85 $666,192 - $1.14 Million	-76,662 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$15.0 - $15.2 $1.15 Million - $1.17 Million	76,662 New	76,662 $1.15 Million

Others Institutions Holding STRO

# of Institutions

128

Shares Held

62.4M

Call Options Held

200

Put Options Held

27.6K

View Full List

About SUTRO BIOPHARMA, INC.

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $216M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

More about STRO

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account